These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23544673)

  • 41. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
    Román O; Cuevas G; Bunout D
    Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diuretics and other antihypertensive drugs and glycemic control in non-insulin-dependent diabetics with hypertension. A survey by the Fukuoka Diabetes Clinic Group.
    Tsutsu N; Nunoi K; Yokomizo Y; Kikuchi M; Fukiyama K; Fujishima M
    Clin Exp Hypertens A; 1989; 11(8):1487-504. PubMed ID: 2575469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study.
    Ruscitti P; Ursini F; Cipriani P; Ciccia F; Liakouli V; Carubbi F; Guggino G; Berardicurti O; Grembiale R; Triolo G; De Sarro G; Giacomelli R
    Medicine (Baltimore); 2017 Aug; 96(34):e7896. PubMed ID: 28834907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired Fasting Glucose (IFG) Prevalence Among Hypolipidemic Treatment- naïve Patients with Hypertension.
    Papadakis J; Ioannou P; Vrentzos G; Theodorakopoulou V; Papanikolaou K; Filippatos T
    Curr Hypertens Rev; 2022; 18(2):153-157. PubMed ID: 35319378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired Fasting Glucose in Nondiabetic Range: Is It a Marker of Cardiovascular Risk Factor Clustering?
    Valentino G; Kramer V; Orellana L; Bustamante MJ; Casasbellas C; Adasme M; Salazar A; Navarrete C; Acevedo M
    Dis Markers; 2015; 2015():804739. PubMed ID: 26504260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose.
    Carnevale R; Pastori D; Nocella C; Cammisotto V; Baratta F; Del Ben M; Angelico F; Sciarretta S; Bartimoccia S; Novo M; Targher G; Violi F
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):890-895. PubMed ID: 28743559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired fasting glucose is associated with increased perioperative cardiovascular event rates in patients undergoing major non-cardiothoracic surgery.
    Biteker M; Dayan A; Can MM; İlhan E; Biteker FS; Tekkeşin A; Duman D
    Cardiovasc Diabetol; 2011 Jul; 10():63. PubMed ID: 21756307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study.
    Hashemi Madani N; Ismail-Beigi F; Poustchi H; Nalini M; Sepanlou SG; Malek M; Abbasi MA; Khajavi A; Khamseh ME; Malekzadeh R
    BMC Cardiovasc Disord; 2020 Mar; 20(1):113. PubMed ID: 32138676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased Vascular Disease Mortality Risk in Prediabetic Korean Adults Is Mainly Attributable to Ischemic Stroke.
    Kim NH; Kwon TY; Yu S; Kim NH; Choi KM; Baik SH; Park Y; Kim SG
    Stroke; 2017 Apr; 48(4):840-845. PubMed ID: 28258257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prevalence and determinants of impaired fasting glucose in the population of Taiwan.
    Chen CM; Yeh MC
    BMC Public Health; 2013 Dec; 13():1123. PubMed ID: 24304589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between blood glucose levels and cardiovascular risk in the Spanish Mediterranean population.
    López-González ÁA; Manzanero Z; Vicente-Herrero MT; García-Agudo S; Gil-Llinás M; Moreno-Morcillo F
    Turk J Med Sci; 2017 Jun; 47(3):754-763. PubMed ID: 28618766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of multiple risk factors for coronary heart disease in patients with hypertension.
    Poulter N
    Am Heart J; 1991 Jan; 121(1 Pt 2):246-9; discussion 249-50. PubMed ID: 1670743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Serum Uric Acid Level with Impaired Fasting Glucose in Adults at a Tertiary Level Hospital of Bangladesh.
    Sharmin F; Roy MN; Junaed MT
    Mymensingh Med J; 2022 Jan; 31(1):88-93. PubMed ID: 34999685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diuretics of beta-blockers first for hypertension?
    Whitworth JA; Kincaid-Smith P
    Drugs; 1982 May; 23(5):394-402. PubMed ID: 6124416
    [No Abstract]   [Full Text] [Related]  

  • 55. Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases.
    Park C; Guallar E; Linton JA; Lee DC; Jang Y; Son DK; Han EJ; Baek SJ; Yun YD; Jee SH; Samet JM
    Diabetes Care; 2013 Jul; 36(7):1988-93. PubMed ID: 23404299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Follow-up study to explore the relationship between Neutrophil to lymphocyte ratio and impaired fasting glucose-using the group-based trajectory modeling.
    Liu X; Peng G; Liu R; Zang X; Zou C; Sun H; Zhu Q; Geng H; Liang J
    Sci Rep; 2024 Jun; 14(1):14064. PubMed ID: 38890369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High incidence of diabetes after stroke in young adults and risk of recurrent vascular events: the FUTURE study.
    Rutten-Jacobs LC; Keurlings PA; Arntz RM; Maaijwee NA; Schoonderwaldt HC; Dorresteijn LD; van der Vlugt MJ; van Dijk EJ; de Leeuw FE
    PLoS One; 2014; 9(1):e87171. PubMed ID: 24466339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin 17A and Toll-like Receptor 4 in Patients with Arterial Hypertension.
    Simundic T; Jelakovic B; Dzumhur A; Turk T; Sahinovic I; Dobrosevic B; Takac B; Barbic J
    Kidney Blood Press Res; 2017; 42(1):99-108. PubMed ID: 28359064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular risk in obese hypertensive patients taking various antihypertensive drugs.
    Schindler C; Bramlage P; Thoenes M; Bramlage C; Kirch W
    Clin Drug Investig; 2007; 27(10):707-17. PubMed ID: 17803346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequency of Exposure to Impaired Fasting Glucose and Risk of Mortality and Cardiovascular Outcomes.
    Lee SH; Han K; Kwon HS; Kim MK
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1007-1015. PubMed ID: 34674499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.